[HTML][HTML] Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer

P Nowak-Sliwinska, L Scapozza, AR i Altaba - Biochimica et Biophysica …, 2019 - Elsevier
The strategy of using existing drugs originally developed for one disease to treat other
indications has found success across medical fields. Such drug repurposing promises faster …

Viruses in colorectal cancer

L Marongiu, H Allgayer - Molecular oncology, 2022 - Wiley Online Library
Increasing evidence suggests that microorganisms might represent at least highly
interesting cofactors in colorectal cancer (CRC) oncogenesis and progression. Still …

Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival

EN Kotnik, MM Mullen, NC Spies, T Li… - Communications …, 2023 - nature.com
High-grade serous ovarian cancer (HGSC) is the most lethal histotype of ovarian cancer and
the majority of cases present with metastasis and late-stage disease. Over the last few …

Locus-specific characterization of human endogenous retrovirus expression in prostate, breast, and colon cancers

MC Steiner, JL Marston, LP Iñiguez, ML Bendall… - Cancer research, 2021 - AACR
Human endogenous retroviruses (HERV) have been implicated in a variety of diseases
including cancers. Recent research implicates HERVs in epigenetic gene regulation. Here …

Therapeutic potential of antiviral drugs targeting chemorefractory colorectal adenocarcinoma cells overexpressing endogenous retroviral elements

D Díaz-Carballo, AH Acikelli, J Klein, H Jastrow… - Journal of Experimental …, 2015 - Springer
Background Endoretroviruses account for circa 8% of all transposable elements found in the
genome of humans and other animals. They represent a genetic footprint of ancestral germ …

Bioinformatics analysis of evolution and human disease related transposable element-derived microRNAs

HE Lee, JW Huh, HS Kim - Life, 2020 - mdpi.com
Transposable element (TE) has the ability to insert into certain parts of the genome, and due
to this event, it is possible for TEs to generate new factors and one of these factors are …

Drug repurposing strategies for non-cancer to cancer therapeutics

S Singhal, P Maheshwari… - Anti-Cancer Agents …, 2022 - ingentaconnect.com
Global efforts invested in the prevention and treatment of cancer need to be repositioned to
develop safe, effective, and economic anticancer therapeutics by adopting rational …

Human endogenous retroviruses long terminal repeat methylation, transcription, and protein expression in human colon cancer

M Dolci, C Favero, W Toumi, E Favi, L Tarantini… - Frontiers in …, 2020 - frontiersin.org
Colon cancer is the fourth most common malignancy in both incidence and mortality in
developed countries. Infectious agents are among the risk factors for colon cancer …

Identification of differentially expressed human endogenous retrovirus families in human leukemia and lymphoma cell lines and stem cells

K Engel, L Wieland, A Krüger, I Volkmer, H Cynis… - Frontiers in …, 2021 - frontiersin.org
Endogenous retroviruses (ERVs) are becoming more and more relevant in cancer research
and might be potential targets. The oncogenic potential of human ERVs (HERVs) has been …

[HTML][HTML] Expression profiles of human endogenous retrovirus (HERV)-K and HERV-R Env proteins in various cancers

EJ Ko, KS Song, MS Ock, YH Choi, S Kim, HS Kim… - BMB …, 2021 - ncbi.nlm.nih.gov
The vertebrate genome contains an endogenous retrovirus that has been inherited from the
past millions of years. Although approximately 8% of human chromosomal DNA consists of …